OrsoBio, Inc. is a privately held, clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders, including type 2 diabetes, severe dyslipidemias, lipodystrophies, and nonalcoholic steatohepatitis. OrsoBio currently has four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism. 

Biotechnology

Health Care

Life Sciences

Therapeutics

OrsoBio

OrsoBio's headquarters in Palo Alto, United States

G. Mani Subramanian

Alex Nguyen

Rob Myers

This department oversees the strategic direction and execution of clinical development activities to ensure the efficient advancement of pharmaceutical products.

Clinical Development Operations

This department is responsible for setting the strategic direction and overall vision of the organization.

Executive Leadership

This department manages financial planning, analysis, and oversight within the organization.

Finance Coordination

This department focuses on conducting scientific research and advancing knowledge in the field of biology.

OrsoBio

Org chart

Teams

Clinical Development Operations

Executive Leadership

Finance Coordination

Research Biology

Offices

OrsoBio

Org chart

Teams

Clinical Development Operations

Executive Leadership

Finance Coordination

Research Biology

Offices

Related companies